Cerebral venous thrombosis and Covid 19: Literature review
- Journal of Neurology & Stroke
-
Carlos Alexandre Martins Zicarelli,Jonathan Vinicius Martins,Wesley Vieira Doni,Rafael Rodrigues Pinheiro dos Santos,Ana Carla Mondek Rampazzo,Gabrielli Algazal Marin,Mariana Ramos do Nascimento,Igor Ruan de Araújo Caetano,Maria Letícia Nogueira,José Ângelo Favoreto Guarnieri,Victor Guilherme Batistela Pereira,Franciele Frazoli,Ivan Hattanda,Leonardo Valente de Camargo
PDF Full Text
Abstract
Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) was first detected in December 2019 in the city of Wuhan, China, and has since taken on worldwide proportions. It is known that individuals with Coronavirus disease-19 (COVID-19) have systemic clinical manifestations. Among the multisystemic effects, cerebral venous thrombosis (CVT) is responsible for high mortality rates. In this sense, understanding the association between CVT and SARS-CoV-2 infection directly impacts the disease's morbidity and mortality.
Keywords
COVID-19, coronavirus, thrombosis, venous thrombosis, central nervous system, intracranial thrombosis
